SCHEMBL8943556

SCHEMBL8943556

NCCN1C(=O)CC2(CCCC2)CC1=O

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTR1A P08908 13/20 0.48
ADRA1B P35368 10/20 0.48
ADRA1A P35348 8/20 0.48
ADRA1D P25100 7/20 0.48
DRD2 P14416 6/20 0.48
SLC22A2 O15244 1/20 0.44
ABCB11 O95342 1/20 0.44
ALDH1A1 P00352 1/20 0.44
CYP1A2 P05177 1/20 0.44
CYP3A4 P08684 1/20 0.44
CYP2D6 P10635 1/20 0.44
CYP2C9 P11712 1/20 0.44
ADRA2C P18825 1/20 0.44
CNR1 P21554 1/20 0.44
HTR2A P28223 1/20 0.44
HTR2C P28335 1/20 0.44
HTR7 P34969 1/20 0.44
HRH1 P35367 1/20 0.44
DRD3 P35462 1/20 0.44
HTR2B P41595 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12557639 0.87 HTR1A (0.52) HTR1AADRA1BADRA1AADRA1DDRD2
Hydrochloric Acid SCHEMBL9424728 0.85 ALDH1A1 (0.52) HTR1AADRA1BADRA1AADRA1DDRD2
SCHEMBL6751068 0.80 HTR1A (0.49) HTR1AADRA1BADRA1AADRA1DDRD2
SCHEMBL9386416 0.80 HTR1A (0.48) HTR1AADRA1BADRA1AADRA1DDRD2
SCHEMBL6580269 0.80 HTR1A (0.48) HTR1AADRA1BADRA1AADRA1DDRD2
SCHEMBL12600977 0.80 HTR1A (0.48) HTR1AADRA1BADRA1AADRA1DDRD2
SCHEMBL6580422 0.78 HTR1A (0.47) HTR1AADRA1BADRA1AADRA1DDRD2
SCHEMBL11608413 0.78 HTR1A (0.47) HTR1AADRA1BADRA1AADRA1DDRD2
SCHEMBL7356006 0.77 HTR1A (0.50) HTR1AADRA1BADRA1AADRA1DDRD2
SCHEMBL10469601 0.77 HTR1A (0.46) HTR1AADRA1BADRA1AADRA1DDRD2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5541326-A PHARMACEUTICAL COMPOSITION USED TO TREAT CENTRAL NERVOUS SYSTEM DISORDERS JOHN WYETH & BROTHER, LIMITED (GB) 1996-07-30 US disclosed
US-5420278-A ω-(4-aryl or heteroarylpiperazine-1-yl)-2-aryl or aralkyl-propanoic or butanoic acids JOHN WYETH & BROTHER, LIMITED (GB) 1995-05-30 US disclosed
US-5382583-A Hydroxytryptamine antagonists JOHN WYETH & BROTHER, LIMITED (GB) 1995-01-17 US disclosed
US-5364849-A Treatment of anxiety JOHN WYETH & BROTHER, LIMITED (GB) 1994-11-15 US disclosed
US-5340812-A Antiserotonin. anxiolytic agents JOHN WYETH & BROTHER, LIMITED (GB) 1994-08-23 US disclosed